Freenome’s CEO Gabe Otte is Putting the Cure for Cancer Within Reach

56 minutes · October 21, 2019

Entrepreneurs Gabe Otte and Riley Ennis hatched Freenome in 2014 to use genomics and machine learning to revolutionize how cancer is diagnosed and treated. He steps Inside the ICE House to share the science behind stopping cancer and how Freenome’s platform allows care to commence when the disease is significantly more curable. The result is a cancer diagnosis, and targeted treatment, that is minimally disruptive to the quality of life and long-term outlook of the patient.

Listen to more episodes

Check out episodes from our previous seasons.

Subscribe to Inside the ICE House

  • Listen on Apple Podcasts
  • Spotify
  • Listen on Stitcher
  • Listen on Google Podcasts
  • Listen on Himalaya
  • RSS

Information contained in this podcast was obtained in part from publicly available sources, and not independently verified. Neither ICE nor its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the information and do not sponsor, approve, or endorse any of the content herein, all of which is presented solely for informational and educational purposes. Nothing herein constitutes an offer to sell, a solicitation of an offer to buy any security, or a recommendation of any security or trading practice.